Ophthalmology Research and Drug Development | Charles River

ophthalmology 

 
 

With the expected changes in demographics over the next 10-15 years, there is a growing need to increase and accelerate the development of safe and effective therapies for eye disorders. Charles River has the necessary understanding of eye-related diseases and conditions as well as the technical ability and experience to guide your new drugs and treatments through the development process as efficiently as possible. 

Through our Preclinical, Clinical, and Research Models products and services groups, we offer you an integrated approach to ophthalmology research. Compounds or implantable devices intended for ocular treatment can be assessed for efficacy, safety, and toxicity. In addition, ocular effects of compounds targeted to non-ocular conditions can also be characterized. 

Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jul 01 Charles River Announces RMS Succes...
Jun 01 Contract Pharma: CRO Industry Upda...
Jul 06-Jul 10 Perth, Australia The 2009 Australian Society for Microbiology (ASM) A...
Aug 18-Aug 21 Charleston, SC Charles River’s Annual LAL Workshop
view all
Quality Assurance Inspector Canada - QC -...
Principal Investigator I Tacoma, WA
Sr. Quality Assurance Auditor Frederick, ...
Global Loss Control Specialist, Finance 

Charles River Laboratories, Inc.